INTRODUCTION
============

The African trypanosome, *Trypanosoma brucei*, is a divergent protozoan pathogen of major medical and economic importance. These parasites are transmitted by tsetse flies and circulate in the mammalian host bloodstream. In order to establish a persistent infection in an immunocompetent host, *T. brucei* undergoes phenotypic and clonal variation of the abundant Variant Surface Glycoprotein (VSG) ([@gks813-B1]). This involves monoallelic *VSG* expression and reversible silencing of other *VSGs*. These genes are found adjacent to telomeres in polycistronic expression sites (ESs) ([@gks813-B2]) that are, unusually, under the control of promoters that recruit RNA polymerase I (RNAP-1). Beyond the *VSG*s found in the ESs, *T. brucei* also possess a subtelomeric and silent archive of up to 2000 *VSG*s and *VSG* pseudogenes ([@gks813-B3]).

The epigenetic mechanisms underlying *VSG* gene silencing and allelic exclusion are not fully understood. RNAP-I is thought to facilitate the high rate of transcription at the active ES, which is found in an extranucleolar region enriched for RNAP-I known as the ES body (ESB) ([@gks813-B4]). All *VSG* ES promoters appear to initiate RNAP-I-mediated transcription, but processivity is poor at silent ESs ([@gks813-B5]), resulting in a vast differential between *VSG* transcription at silent and active ESs. Recently, the single active *VSG* ES was shown to be specifically depleted of nucleosomes ([@gks813-B6],[@gks813-B7]) and, in the past 5 years, several chromatin-associated factors required to maintain effective silencing at other ESs have been identified: the chromatin remodeller, ISWI ([@gks813-B8]); the histone (H3K76) methyltransferase, DOT1B (disruption of telomeric silencing) ([@gks813-B9]); the telomere-binding protein, RAP1 (repressor activator protein) ([@gks813-B10]); a histone deacetylase, DAC3 ([@gks813-B11]); the chromatin remodelling chaperone, FACT (facilitates chromatin transcription) ([@gks813-B12]); a nucleoplasmin-like protein, NLP ([@gks813-B13]); and the lamin-like NUP-1 (nuclear periphery protein-1) ([@gks813-B14]). All, but the methyltransferase are essential for growth, and their depletion typically reveals pronounced derepression close to the ES promoter, linking chromatin structure to *VSG* ES silencing. An impact on the *VSG* itself has been detected following ISWI, DOT1B, RAP1 or NUP-1 depletion, but in every case, derepression is far from complete.

Taken together, the findings detailed above show that chromatin-associated factors play an important role in defining active and silent ESs. However, incomplete derepression suggests incomplete disruption of repressive chromatin when these factors are depleted. Using data derived from a genome-scale RNA interference viability screen ([@gks813-B15]), we selected five putative essential genes with the potential to play a role in chromatin-based gene silencing. These genes were characterized and assessed in a *VSG* ES silencing assay, revealing both histone chaperones, CAF-1b and ASF1A, as cell cycle progression regulators and *VSG* ES regulators. Knockdown of these chaperones or a core histone (H3) resulted in different cell cycle stage-regulated patterns of derepression at a silent *VSG* ES. Our findings provide insights into the functions of these conserved chromatin regulators and strongly support a role for chromatin in maintaining silent *VSG* ESs. In particular, the findings also illuminate cell cycle checkpoints that limit progression to the derepressed state.

MATERIALS AND METHODS
=====================

Strains
-------

MiTat 1.2, clone 221a ([@gks813-B16]) bloodstream-form *T. brucei*, 2T1 cells and 2T1 cells modified with a tetracycline-regulated green fluorescent protein:neomycin phospotransferase (*GFP:NPT)* cassette immediately downstream of the *VSG221* ES promoter ([@gks813-B11]), were maintained, transfected and differentiated to the insect stage as previously described ([@gks813-B17]). The modified ES was maintained in the fully active state in the presence of 1 μg/ml tetracycline ('active ES') or rendered inactive following the removal of tetracycline (ES2^GN^); this latter cell line was used in all subsequent experiments. Transformants were selected with blasticidin (10 μg/ml) or hygromycin (2.5 μg/ml), as appropriate. For growth assays, cultures were seeded at ∼10^5^/ml, diluted back and counted daily using a haemocytometer.

Plasmid construction
--------------------

The pRPa^iSL^ and pNAT constructs ([@gks813-B18]) were modified to target *CAF-1b*, *ASF1A*, *C/EBP-NOC1*, *BDF5*, *TDP-1* and histone H3 for stem--loop RNAi and to engineer 12 cMYC epitope tags at the *C*-terminus of a native allele for the first five genes. For RNAi, ORFs were subjected to the RNAit primer prediction algorithm ([@gks813-B19]), designed to minimize potential off-target effects. In the case of histone H3, the entire open reading frame (ORF) served as the RNAi target. This sequence (see Tb927.1.2430 for example) is not expected to target the histone H3 variant sequence (Tb927.10.15350); \<60% identity, longest perfect match = 8 nt, no 25 nt stretch with less than six mismatches. All primer sequences are available upon request. Constructs for RNAi and/or cMYC-tagging were transferred to ES2^GN^ cells using a nucleofector apparatus (Lonza) in conjunction with cytomix or T-cell nucleofection solutions.

Protein analysis
----------------

Immuno-blotting was carried out following SDS--PAGE of whole-cell lysates. Protein separation and electroblotting were carried out according to standard protocols and an enhanced chemiluminescent kit (GE Healthcare) was used according to the manufacturer's instructions. Immunofluorescence was carried out as previously described ([@gks813-B20]). cMYC fusions were detected using monoclonal mouse anti-cMYC (9E10, Source BioScience; 1:5000 WB, 1:400 IF), GFP-NPT was detected with polyclonal rabbit anti-NPT (Europa; 1:2000 WB).

Cell cycle analysis
-------------------

Cell cycle analysis was carried out using DNA staining and microscopy or flow cytometry. For microscopy, cells were fixed and settled on slides as for immunofluorescence, mounted in Vectashield (vector Laboratories) containing the DNA counterstain 4,6-diamidino-2-phenylindole (DAPI), and scored for number of nuclei and kinetoplasts. Bloodstream-form cells were exposed to hydroxyurea (10 μg/ml) at a density of 1 × 10^6^/ml and grown for 4--7 h prior to analysis. For flow cytometry, cells were washed in PBS, fixed in 70% methanol 30% PBS overnight at 4°C and stained with propidium iodide (10 μg/ml in PBS containing 10 μg/ml RNAse A) for 45 min at 37°C. Analysis was carried out using a FACScalibur (Becton Dickinson) and Flowjo 7 analysis software; best fit cell cycle models were defined using each uninduced cell line and applied to the matching induced populations.

Chromatin analysis
------------------

Micrococcal nuclease treatment was carried out as previously described ([@gks813-B6]). Briefly, 1 × 10^8^ digitonin-permeabilized bloodstream-form cells were treated with seven gel units of micrococcal nuclease (New England Biolabs) for 10--60 min at 37°C. DNA was isolated using a Qiagen Mini Elute PCR kit and fractionated on a 2% agarose gel. Nuclease-resistant DNA was visualized by staining with ethidium bromide.

RESULTS
=======

Identification of candidate *VSG* ES regulators
-----------------------------------------------

Six of the seven factors known to have an impact on *VSG* ES silencing are essential for viability in bloodstream-form *T. brucei*; only DOT1B is dispensable, but *VSGs* remain repressed and antigenic variation continues to operate in *dot1b* null cells ([@gks813-B9]). All of these genes, as well as a second FACT subunit (POB3), reported the expected fitness phenotype in a recent genome-wide RNA interference (RNAi) target sequencing (RIT-seq) analysis ([@gks813-B15]) ([Figure 1](#gks813-F1){ref-type="fig"}). We sought to identify new candidate chromatin regulators that may play a role in *VSG* ES silencing. To focus on essential functions, we browsed annotations for 1203 genes (16% of a non-redundant gene set) that displayed a highly significant loss-of-fitness (*z*-score \> 5) in the BF^T1^ RIT-seq screen, involving knockdown in bloodstream-form cells for 3 days ([@gks813-B15]). We identified a high-mobility group protein, TDP-1 ([@gks813-B21]), two histone chaperones, CAF-1b and ASF1A ([@gks813-B22]) and two conserved hypothetical genes encoding a double acetyl--lysine binding bromodomain protein, BDF5, and a protein with homology to both a mammalian CAATT-box enhancer-binding protein and a nucleolar factor, C/EBP-NOC1 ([Figure 1](#gks813-F1){ref-type="fig"}). Analysis of CAF-1b from *T. brucei*, *Trypanosoma cruzi* and *Leishmania major* revealed that the trypanosomatid proteins contain the characteristic *N*- and *C*-terminal WD-40 domains (data not shown). Figure 1.Candidate *VSG* ES regulators. (**A**) The plot shows the BF^T1^ outputs from a genome-scale RNAi screen for viability; RNAi induced in bloodstream-form cells for 3 days. Previously identified *VSG* ES regulators, new candidate regulators and core histones are highlighted. A *z*-score \>3.3 indicates statistical significance. (**B**) Heat maps showing previously identified and new candidate *VSG* ES regulators. BF^T1^, as above; BF^T2^, RNAi induced in bloodstream-form cells for 6 days; PF, RNAi induced in procyclic cells; DIF, RNAi induced throughout differentiation from bloodstream to procyclic form. Red indicates a loss-of-fitness. Data derived from previous study ([@gks813-B15]).

Candidate *VSG* expression site regulators are nuclear and essential for bloodstream-form growth
------------------------------------------------------------------------------------------------

For each of the five selected genes, we established strains containing an epitope-tagged allele. Immunofluorescence analysis revealed nuclear localization for CAF-1b, TDP-1 and BDF5 ([Figure 2](#gks813-F2){ref-type="fig"}). The nucleolar localization of C/EBP-NOC1 indicated that this is most likely orthologous to the nucleolar factor, NOC1. We were unable to localize ASF1A^12MYC^. Figure 2.Candidate *VSG* ES regulators localize to the nucleus. Immunofluorescence detection of epitope-tagged proteins; the regions outlined in the phase panels indicate the regions shown in the (immuno)fluorescence panels. The nucleus (N) and kinetoplast (K, mitochondrial genome) were stained with the DNA intercalating dye, DAPI. Scale bar, 5 µm.

All five genes were then analysed by RNAi. We assembled multiple independent strains with inducible stem--loop RNAi constructs against each gene, and monitored growth following RNAi induction in bloodstream-form cells and in the same strains that had been differentiated to the procyclic or insect-stage. In bloodstream-form cells, we saw a severe growth defect for all five genes ([Figure 3](#gks813-F3){ref-type="fig"}A), as predicted by RIT-seq analysis ([Figure 1](#gks813-F1){ref-type="fig"}). Three of the genes (CAF-1b, ASF1A and BDF5) were predicted by RIT-seq to be associated with a growth defect following knockdown in insect-stage cells, although only the ASF1A defect was significant, whereas NOC1 and TDP1 knockdowns were predicted to have little effect on growth. All, but NOC1 displayed the expected growth phenotype ([Figure 3](#gks813-F3){ref-type="fig"}B). The stage-specific growth defect seen in the TDP-1 knockdown strain suggests that this high-mobility group-related protein plays a particularly important role in bloodstream-stage nuclei. Figure 3.Candidate *VSG* ES regulators are essential for bloodstream stage cell survival. Growth curves for (**A**) bloodstream and (**B**) insect stage cells following induction of RNAi (+Tet). In each case, data were derived from four and two independent strains, respectively. Error bars represent 1 SD (standard deviation). RNAi was induced in the presence of 1 μg/ml tetracycline.

CAF-1b and ASF1A maintain *VSG* expression site silencing
---------------------------------------------------------

Our next step was to assemble RNAi strains with an epitope-tagged allele and a *GFP:NPT*-reporter cassette immediately downstream of a repressed *VSG* ES promoter ([Figure 4](#gks813-F4){ref-type="fig"}A); this was achieved as described previously ([@gks813-B11],[@gks813-B23]). Western blot analysis was used to assess knockdown of each tagged candidate regulator and to monitor the *VSG* ES reporter in parallel. To minimize the possibility of observing 'secondary' defects brought on by the toxic effects of the knockdown, we restricted the analysis to the first 24 h following RNAi induction. RNAi strains show little evidence of reduced cell number relative to the control at this point, whereas major growth defects are seen 48 h after induction of RNAi ([Figure 3](#gks813-F3){ref-type="fig"}A); hence, we expected to focus on 'early' defects linked to the action of each protein at 24 h. Monitoring of the tagged proteins revealed efficient knockdown in each case after 24 h ([Figure 4](#gks813-F4){ref-type="fig"}B). The *VSG* ES reporter revealed pronounced derepression following knockdown of either histone chaperone (CAF-1b or ASF1A), but little or no detectable derepression in the case of any of the other knockdowns ([Figure 4](#gks813-F4){ref-type="fig"}B); the derepression phenotype was confirmed in two independent strains for each chaperone. Although the *VSG* ES promoter-proximal reporter was derepressed, we saw no evidence for derepression of the promoter-distal *VSG221* gene ([Figure 4](#gks813-F4){ref-type="fig"}B). Figure 4.Histone chaperones maintain *VSG* ES silencing. (**A**) Schematic map indicating the location of the *GFP:NPT* reporter downstream of the silent *VSG221* ES promoter; these cells express *VSGX* from a different ES. (**B**) CAF-1b or ASF1A knockdown coincides with derepression of a silent *VSG* ES in bloodstream-form cells; data from two independent strains shown for CAF-1b and ASF1A. Coomassie (coo)-stained gels serve as loading controls. RNAi was induced in the presence of 1 μg/ml tetracycline for 24 h.

Histones maintain *VSG* expression site silencing
-------------------------------------------------

The active *VSG* ES is known to be depleted of nucleosomes ([@gks813-B6],[@gks813-B7]), but it has not been shown that histones or nucleosomes are required for *VSG* ES repression. Histone chaperones may maintain *VSG* ES silencing by recycling histones and by loading new histones at silent *VSG* ESs following DNA replication. They may also recycle histones following low-level RNAP-I transcription adjacent to *VSG* ES promoters ([@gks813-B5]). To directly assess the consequences of a deficiency in new histones, we assembled histone H3 knockdown strains with a *VSG* ES reporter. We then demonstrated histone H3 protein knockdown in these strains ([Figure 5](#gks813-F5){ref-type="fig"}A); depletion is likely restricted by the rapid cell-cycle arrest and the persistence of chromatin-associated histones in these cells. As expected, we observed a rapid and severe growth defect associated with histone H3 knockdown ([Figure 5](#gks813-F5){ref-type="fig"}B). In this case, to focus on early phenotypes, we analysed cells up to 7 h after induction of RNAi. Three independent clones, in which histone H3 was depleted, all displayed derepression of the *VSG* ES promoter-proximal reporter but, again, we saw no derepression of the downstream *VSG221* gene ([Figure 5](#gks813-F5){ref-type="fig"}C). These results indicate for the first time that the histones themselves are required to maintain strong *VSG* ES silencing. Figure 5.Histone H3 depletion leads to *VSG* ES derepression. (**A**) Western blot showing depletion of histone H3. (**B**) Histone H3 RNAi knockdown leads to a severe growth defect and (**C**) derepression of a previously silent *VSG221* ES promoter in bloodstream-form cells after 7-h induction, as determined by western blotting. Coomassie-stained gels serve as loading controls. Data derived from three independent strains. Error bars represent 1 SD. RNAi was induced in the presence of 1 μg/ml tetracycline.

Only histone deficient cells that proceed to G~2~/M derepress *VSG* expression sites
------------------------------------------------------------------------------------

We wanted to explore the role of the histone chaperones during the cell cycle, and also whether *VSG* ES derepression occurred at different points through the cell cycle. We began by using microscopy and flow cytometry to explore cell cycle defects associated with histone H3 knockdown. Nuclear and mitochondrial (kinetoplast) DNA, stained with DAPI, provide excellent cytological markers that define the position in the cell cycle ([@gks813-B24]). During normal growth, ∼80% of cells display a single kinetoplast and a single nucleus (1K1N), corresponding to G~1~/S phase. Two kinetoplasts and a single nucleus (2K1N) correspond to nuclear G~2~/M, and the presence of two kinetoplasts and two nuclei (2K2N) indicates completion of mitosis. Since kinetoplast and nuclear cycles may become uncoupled in perturbed cells, we also assessed the progress of nuclear DNA replication using flow cytometry. Flow cytometry was additionally used to monitor *VSG* ES reporter fluorescence levels during cell cycle progression.

Cells depleted for histone H3, and stained with DAPI, displayed a severe cell cycle defect, characterized by a failure to progress to mitosis and indicated by an accumulation of 2K1N cells after 7-h induction ([Figure 6](#gks813-F6){ref-type="fig"}A). Flow cytometry revealed that this was due to a failure to complete DNA replication, leading to an accumulation of cells in S-phase ([Figure 6](#gks813-F6){ref-type="fig"}B). This DNA-replication defect is evident within 4 h of induction of histone H3 RNAi, when the proportion of S-phase cells is already increased by almost 2-fold. However, no effect on *VSG* ES reporter levels was seen until 7 h post-induction, when a population of ∼5% GFP-positive cells emerged, exhibiting a mean 11-fold increase in GFP fluorescence. This GFP reporter expression is still substantially less than when the *VSG* ES is fully active; cells with an active *VSG* ES exhibit a mean 141-fold increase in GFP fluorescence relative to cells with an inactive *VSG* ES ([Figure 6](#gks813-F6){ref-type="fig"}C). Notably, the GFP derepression we observed, coincided with an increase in the G~2~/M population, indicating that a proportion of the defective cells completed DNA replication. Indeed, it was these cells that specifically exhibited *VSG* ES derepression; 80% of the GFP-positive population had completed DNA replication ([Figure 6](#gks813-F6){ref-type="fig"}D). Figure 6.Histone H3 depletion triggers an S-phase defect and G~2~/M-specific *VSG* ES derepression. (**A**) Analysis of DAPI-stained cells after 7-h induction of histone H3 RNAi. K, kinetoplast; N, nucleus. Data derived from three independent strains. Error bars represent 1 SD. (**B**) Flow cytometry analysis showing cell cycle population distributions (left hand panels) and GFP fluorescence levels (right hand panels) after 4 and 7 h of induction. (**C**) Flow cytometry analysis showing GFP fluorescence from wild-type cells (upper panel) and cells with the *GFP:NPT* cassette at the active *VSG221* ES promoter (lower panel). (**D**) Flow cytometry analysis of the GFP positive population from B; histone H3 RNAi for 7 h. Horizontal lines indicate the cell cycle stages, and inset table details the distribution of cells in each stage. RNAi was induced in the presence of 1 μg/ml tetracycline.

These results indicate two temporally distinct responses to histone H3 depletion. First, a drop in histone H3 mRNA and protein in S-phase, when it would normally be abundant ([@gks813-B25]), blocks DNA replication. Second, some cells escape this blockade and, presumably due to nucleosome depletion, derepress the previously silent *VSG* ES reporter.

To distinguish between derepression as a consequence of perturbed histone deposition rather than S-phase checkpoint activation, we treated cells with hydroxyurea, which is thought to inhibit ribonucleotide reductase, deplete dNTP synthesis and thereby stall DNA replication ([@gks813-B26]). Hydroxyurea substantially increased the proportion of 2K1N cells after 4 and 7 h, as expected, but failed to induce any detectable derepression of the ^GFP^NPT reporter at the *VSG* ES ([Supplementary Figure S1](http://nar.oxfordjournals.org/cgi/content/full/gks813/DC1)). Thus, derepression is likely to be a consequence of perturbed histone deposition, rather than of checkpoint activation. We also examined cell cycle progression in cells depleted for the other candidate regulators, BDF5, NOC1 and TDP-1. These knockdowns had little impact on cell cycle distribution as determined by DAPI-staining ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gks813/DC1)A). In addition, because BDF5 depletion produced a very minor, but detectable, derepression of the ^GFP^NPT reporter at the *VSG* ES ([Figure 4](#gks813-F4){ref-type="fig"}), we also carried out flow cytometry analysis, as described above, for this knockdown ([Supplementary Figure S2](http://nar.oxfordjournals.org/cgi/content/full/gks813/DC1)B and C).

ASF1A deficient cells derepress *VSG* expression sites throughout the cell cycle
--------------------------------------------------------------------------------

We next carried out a similar analysis to that described above in cells depleted for ASF1A. Analysis of DAPI-stained cells following ASF1A depletion revealed a similar pattern to that seen following histone H3 depletion, namely an increase in 2K1N cells, indicating a failure to progress to mitosis ([Figure 7](#gks813-F7){ref-type="fig"}A). Flow cytometry revealed that ASF1A depletion primarily increased the proportion of cells in S-phase ([Figure 7](#gks813-F7){ref-type="fig"}B), as previously reported ([@gks813-B22]). Flow cytometry also confirmed that ASF1A depletion results in *VSG* ES derepression, and reports a mean 10-fold increase in *VSG* ES reporter fluorescence in ∼4% of the population. As expected, the ASF1A defect is not associated with a detectable change in steady-state histone H3 levels ([Figure 7](#gks813-F7){ref-type="fig"}C). In striking contrast to histone H3 depletion, ASF1A depletion leads to *VSG* ES reporter derepression at all stages of the cell cycle ([Figure 7](#gks813-F7){ref-type="fig"}D), suggesting a replication-independent role for this histone chaperone. Figure 7.Depletion of ASF1A leads to *VSG* ES derepression at all cell cycle stages. (**A**) Analysis of DAPI-stained cells after 24-h induction of ASF1A RNAi. Data were derived from two independent strains. Error bars represent 1 SD. (**B**) Flow cytometry analysis showing cell cycle population distributions (left hand panels) and GFP fluorescence levels (right hand panels) after 24-h induction. (**C**) Western blot showing histone H3 levels following ASF1A depletion. The coomassie (coo)-stained gel serves as a loading control. (**D**) Flow cytometry analysis of the GFP-positive population. Other details as in [Figure 6](#gks813-F6){ref-type="fig"}D.

CAF-1b deficient cells derepress *VSG* expression sites in S-phase and G~2~/M
-----------------------------------------------------------------------------

Analysis of DAPI-stained cells revealed a similar pattern following RNAi against CAF-1b as seen following histone H3 and ASF1A depletion; an increase in 2K1N cells, indicating a failure to progress to mitosis ([Figure 8](#gks813-F8){ref-type="fig"}A). Flow cytometry revealed that CAF-1b depletion increased the proportion of cells in S-phase and G~2~/M ([Figure 8](#gks813-F8){ref-type="fig"}B), again indicating a DNA replication defect. Flow cytometry also confirmed that CAF-1b depletion results in *VSG* ES derepression, and reports a mean 13-fold increase in *VSG* ES reporter fluorescence in 29% of the population ([Figure 8](#gks813-F8){ref-type="fig"}B). As was the case with ASF1A, CAF-1b depletion and the associated phenotypes were not associated with a detectable change in histone H3 steady state levels ([Figure 8](#gks813-F8){ref-type="fig"}C). In the case of CAF-1b-depleted cells, the *VSG* ES reporter was derepressed in S-phase and G~2~/M, but displayed little derepression in G~1~ ([Figure 8](#gks813-F8){ref-type="fig"}D), suggesting that CAF-1 is primarily a replication-dependent histone chaperone. Note that only 'new' histones are expected to be depleted following RNAi against histone H3, whereas both 'old' and 'new' histone (re)assembly is expected to be defective in chaperone-depleted cells. Figure 8.Depletion of CAF-1b leads to *VSG* ES derepression during S-phase and G~2~/M. (**A**) Analysis of DAPI-stained cells after 24-h induction of CAF-1b RNAi. Data were derived from two independent strains. Error bars represent 1 SD. (**B**) Flow cytometry analysis showing cell cycle population distributions (left hand panels) and GFP fluorescence levels (right hand panels) after 24-h induction. (**C**) Western blot showing histone H3 levels following CAF-1b depletion. The coomassie (coo)-stained gel serves as a loading control. (**D**) Flow cytometry analysis of the GFP positive population from B. Other details as in [Figure 6](#gks813-F6){ref-type="fig"}D. (**E**) Nucleosome ladders generated by micrococcal nuclease digestion; equal numbers of cells were analysed in each sample and digestion was carried out between 10 and 60 min.

To directly examine the status of nucleosomes in CAF-1b-depleted cells, we partially digested chromatin from these cells with micrococcal nuclease (MNase). The resulting ladders of digestion products correspond to regularly spaced nucleosomes ([Figure 8](#gks813-F8){ref-type="fig"}E). CAF-1b depletion does not appear to have a substantial impact on global nucleosome spacing, but the reduced intensity of the ladder does indicate nucleosome depletion ([Figure 8](#gks813-F8){ref-type="fig"}E). These results, confirmed in independent strains ([Supplementary Figure S3](http://nar.oxfordjournals.org/cgi/content/full/gks813/DC1)), are consistent with CAF-1 independent DNA replication through parental nucleosomes ([@gks813-B27],[@gks813-B28]), but reduced nucleosome segregation or assembly on nascent DNA. The results also suggest a direct link between nucleosome assembly and maintenance of *VSG* ES repression.

DISCUSSION
==========

Evidence has emerged in recent years for chromatin-based control of silent *VSG* ESs. We sought to identify other genes involved in this process and to further characterize the role of chromatin and histones in maintaining the silent state. Taking outputs from a genetic screen for viability, we selected five essential genes with a putative role in chromatin structure and function. Taken together, our findings reveal surveillance of chromatin integrity in *T. brucei* and delayed S-phase progression in response to reduced histone or chaperone dosage. We link histone H3 and two new histone chaperones to *VSG* ES silencing, and reveal derepression in subpopulations of histone-depleted cells that proceed to G~2~/M phase and in subpopulations of chaperone-depleted cells predominantly in S-phase and G~2~/M; derepression is notably later in the cell cycle in CAF-1b-depleted cells.

The importance of chromatin structural integrity in the maintenance of the repressed state at *VSG* ES loci is demonstrated by the consequences of histone H3 knockdown. Cells rapidly accumulate in S-phase within 4 h of RNAi induction, suggesting that S-phase checkpoint surveillance senses reduced histone availability. Importantly though, a silent *VSG* ES was derepressed only in the small proportion of cells that progressed beyond S-phase, and even in these cells, the silent *VSG* itself was not derepressed. This indicates that perturbation of chromatin structure that is sufficient to trigger cell cycle arrest and to disrupt monoallelic *VSG* ES transcription is insufficient to allow transcription to extend though the silent *VSG* ES.

Histone chaperones disassemble and assemble nucleosomes. The entire genome must be replicated, so this function is equally important at transcribed and non-transcribed loci, and chromatin differences must be reinstated behind the replication fork to maintain cellular phenotypes. These chaperones may also serve replication-independent functions. Recent reviews focusing on histone chaperones detail roles in replication and repair ([@gks813-B29]), structure--function relationships ([@gks813-B30]) and crosstalk with histone post-translational modifications (PTMs) and the inheritance of epigenetic states ([@gks813-B31]). The chaperones we identify are orthologues of ASF1 and CAF-1. The genes encoding these proteins are dispensable in the yeast, *Saccharomyces cerevisiae* ([@gks813-B32]), possibly due to redundancy with other related functions, but essential in mammalian or other vertebrate cells. Depletion of either vertebrate ASF1 ([@gks813-B33]) or CAF-1 ([@gks813-B34],[@gks813-B35]) leads to accumulation in S-phase, and these histone chaperones have also been linked to chromatin-based silencing in yeast ([@gks813-B36; @gks813-B37; @gks813-B38; @gks813-B39]) and mammals ([@gks813-B40]), similar to the situation we now observe in trypanosomes.

*Trypanosoma brucei* FACT, a histone H2A-H2B chaperone, was previously linked to *VSG* ES silencing ([@gks813-B12]). FACT in other eukaryotes appears to fulfil a primarily replication-independent function by displacing H2A-H2B dimers ([@gks813-B41]), though there is also evidence supporting a role during replication ([@gks813-B42]). In contrast, CAF-1 has a primarily replication-associated role, recycling and assembling H3-H4 dimers into chromatin, whereas ASF1 is involved in recycling and assembly of H3-H4 dimers during DNA replication and transcription ([@gks813-B31]). There are two ASF1-related proteins in *T. brucei*, both of which play a role in S-phase progression (22 and this study). *Trypanosoma brucei* CAF-1b also functions in S-phase progression (this study), whereas FACT does not ([@gks813-B12]), suggesting replication-associated and replication-independent roles, respectively.

Our data now indicate that CAF-1b and ASF1A are important for the maintenance and inheritance of epigenetically determined states at silent telomeric *VSG* ESs in *T. brucei*. ASF1 and CAF-1 are highly conserved from yeast to mammals. In these organisms, ASF1 appears to play a role in disassembly ahead of the replication fork and the recycling of old histones and their PTMs, by passing these histones to CAF1, which is thought to participate in chromatin assembly directly behind the passing DNA polymerase ([@gks813-B31]). ASF1 has a similar function in histone recycling during transcription ([@gks813-B31]), and has recently been shown to play a role in heterochromatin assembly in *Schizosaccharomyces pombe* ([@gks813-B39]). Thus, the inheritance of epigenetic states is thought to depend upon the reassembly of locally displaced nucleosomes ([@gks813-B43]), thereby re-establishing the prior nucleosomes and their modifications, initially in a hemi-modified form, which could then serve as a signal for the addition of further similar modifications. Histone H3K56 acetylation appears to be central to this process, and for checkpoint signalling ([@gks813-B44]). Although an equivalent PTM has yet to be identified in trypanosomatids, the cell cycle and loss-of-silencing phenotypes that we identified associated with either ASF1A or CAF-1b knockdown are consistent with these chaperones functioning in conserved transcription/replication and replication-associated pathways, respectively.

Three distinct histone chaperones have now been linked to *VSG* ES silencing in *T. brucei*. Notably, knockdown of each factor brings about a distinct cell-cycle-regulated pattern of derepression. FACT depletion leads to G~2~/M specific derepression but no apparent delay in S-phase ([@gks813-B12]), possibly indicating a post-S-phase role. ASF1A depletion delays S-phase and causes derepression in a subpopulation of cells through the cell cycle, consistent with a constitutive role in histone loading and recycling; the recycling role during G~1~ is likely to be important to maintain attenuation of transcription at silent *VSG* ESs ([@gks813-B5]). CAF-1b depletion delays S-phase and primarily causes derepression during S-phase and G~2~/M, consistent with a histone loading role during S-phase. Thus, our results indicate conserved histone chaperone functions for both ASF1A and CAF-1b from trypanosomes to humans. We conclude that chaperone-dependent chromatin reassembly following attenuated transcription (ASF1A) and DNA replication (ASF1A and CAF-1b) are essential for the maintenance of *VSG* ES silencing. In addition, we show that cell cycle checkpoints often limit progression to the derepressed state in chromatin-perturbed cells.
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